Oxford Biodynamics PLC (LON:OBD) Chief Executive Officer Christian Hoyer Millar caught up with DirectorsTalk for an exclusive interview to discuss GL Capital’s stake in the company.   Q1: This morning ...

Oxford BioDynamics Plc (LON:OBD) CEO Christian Hoyer Millar talks to DirectorsTalk about with its co-operation agreement with GL Capital Group to address the growing demand for healthcare and personalised medicine ...

Shares of Mediclinic International PLC EPIC code: LON:MDC has risen 3.41% or 16.2 points throughout today’s trading session so far. Market buyers have remained positive throughout the session. The periods ...

Oxford BioDynamics Plc (LON:OBD) announced today that it has entered into a Co-operation Agreement with GL Capital Group to address the growing demand for healthcare and personalised medicine in China. ...

Oxford Biodynamics PLC (LON:OBD) Chief Scientific Officer Dr Alexandre Akoulitchev caught up with DirectorsTalk for an exclusive interview to discuss their recent work published at the Summit on Emerging Immunotherapies ...

Oxford Biodynamics Plc (LON:OBD) CSO Dr Alexandre Akoulitchev talks to DirectorsTalk about presenting its work in Washington at the Summit on Emerging Immunotherapies for Hematologic Diseases. Alexandre describes for us ...

Oxford BioDynamics Plc (LON:OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, today ...

Oxford BioDynamics Plc (LON:OBD), a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, has ...

Oxford Biodynamics PLC (LON:OBD) Chief Scientific Officer Dr Alexandre Akoulitchev caught up with DirectorsTalk for an exclusive interview to discuss their recent publication in EBioMedicine, more about the biomarkers and the ...

Oxford BioDynamics Plc (LON:OBD) CSO Dr Alexandre Akoulitchev explains to DirectorsTalk how the OBD work on ALS published in EBioMedicine fits into the bigger picture around this disease, the nature ...